Drug Shortage Report for VENLAFAXINE XR
Report ID | 205261 |
Drug Identification Number | 02516551 |
Brand name | VENLAFAXINE XR |
Common or Proper name | Venlafaxine Hydrochloride Extended-Release Capsules |
Company Name | JAMP PHARMA CORPORATION |
Market Status | MARKETED |
Active Ingredient(s) | VENLAFAXINE |
Strength(s) | 150MG |
Dosage form(s) | CAPSULE (EXTENDED RELEASE) |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | N06AX |
ATC description | ANTIDEPRESSANTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2023-09-29 |
Estimated end date | 2024-06-30 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-03-30 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1310 RUE NOBEL BOUCHERVILLE, QUEBEC CANADA J4B 5H3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v11 | 2024-03-30 | French | Compare |
v10 | 2024-03-30 | English | Compare |
v9 | 2024-02-06 | French | Compare |
v8 | 2024-02-06 | English | Compare |
v7 | 2023-12-30 | French | Compare |
v6 | 2023-12-30 | English | Compare |
v5 | 2023-11-15 | French | Compare |
v4 | 2023-11-15 | English | Compare |
v3 | 2023-09-30 | English | Compare |
v2 | 2023-09-26 | French | Compare |
v1 | 2023-09-26 | English | Compare |
Showing 1 to 11 of 11